mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.007 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.007 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.008 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |